Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice

Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice focuses on the critical role of biomarkers and predictive factors in breast pathology, aiming to bridge the gap between research discoveries and their practical application in clinical practice. The sessions within this track will explore the latest advancements in identifying and understanding biomarkers that aid in the diagnosis, prognosis, and treatment selection for breast cancer patients. From genomic and proteomic markers to hormone receptors and HER2/neu status, experts will discuss the clinical implications, validation studies, and guidelines for incorporating these biomarkers into routine practice. Attendees will gain valuable insights into how biomarkers and predictive factors are transforming breast pathology and enhancing personalized patient care.

  • Biomarkers for Predicting Response to Therapy
  • Prognostic Biomarkers in Breast Pathology

Related Conference of Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice

December 14-15, 2023

5th International Conference on Oncology and Cancer

Rome, Italy
February 22-23, 2024

14th World Congress on Breast Cancer

Zurich, Switzerland
March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
April 18-19, 2024

24th World Congress on Cancer and Diagnostics

Dubai, UAE

Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in